3//SEC Filing
Dullinger Ronald 3
Accession 0001171843-26-000173
CIK 0000882796other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 7:19 PM ET
Size
20.6 KB
Accession
0001171843-26-000173
Insider Transaction Report
Form 3
Dullinger Ronald
Chief Commercial Officer
Holdings
- 258,372
Common Stock
Emp. Stock Option (Right to Buy)
Exercise: $2.85From: 2020-11-29Exp: 2029-11-29→ Common Stock (100,000 underlying)Emp. Stock Option (Right to Buy)
Exercise: $8.31From: 2021-12-15Exp: 2030-12-15→ Common Stock (100,000 underlying)Emp. Stock Option (Right to Buy)
Exercise: $11.43From: 2022-12-14Exp: 2031-12-14→ Common Stock (41,000 underlying)Emp. Stock Option (Right to Buy)
Exercise: $10.63From: 2023-12-19Exp: 2032-12-19→ Common Stock (57,100 underlying)Emp. Stock Option (Right to Buy)
Exercise: $6.43From: 2024-12-14Exp: 2033-12-14→ Common Stock (57,100 underlying)Emp. Stock Option (Right to Buy)
Exercise: $7.39From: 2025-12-19Exp: 2034-12-19→ Common Stock (68,500 underlying)Emp. Stock Option (Right to Buy)
Exercise: $7.13From: 2026-12-17Exp: 2035-12-17→ Common Stock (255,050 underlying)
Footnotes (8)
- [F1]Includes 206,813 restricted stock units which vest 25% on each of the first, second, third and fourth anniversaries of the date of grant.
- [F2]Annual Employee Option Grant became exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant. The option was granted on November 29, 2019.
- [F3]Annual Employee Option Grant became exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant. The option was granted on December 15, 2020.
- [F4]Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant. The option was granted on December 14, 2021.
- [F5]Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant. The option was granted on December 19, 2022.
- [F6]Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant. The option was granted on December 14, 2023.
- [F7]Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant. The option was granted on December 19, 2024.
- [F8]Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant. The option was granted on December 17, 2025.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0002103871
Filing Metadata
- Form type
- 3
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 7:19 PM ET
- Size
- 20.6 KB